2023-08-28 18:00:00 ET
If you are looking for some high-octane growth stocks to add to your portfolio, you might want to follow in the footsteps of some of the most successful investors in the biotech sector. Baker Bros. Advisors, a hedge fund founded by billionaire brothers Julian and Felix Baker, has a stellar track record of picking winners in the healthcare space. The fund has over $23 billion in assets under management and focuses on companies that are developing innovative therapies for unmet medical needs.
Two of the fund's top holdings are Acadia Pharmaceuticals (NASDAQ: ACAD) and Roivant Sciences (NASDAQ: ROIV) , both of which have delivered impressive returns in the past year. Acadia is a leader in the field of neuropsychiatric disorders, with two Food and Drug Administration (FDA)- approved products on the market for Parkinson's disease psychosis (Nuplazid) and Rett syndrome (Daybue).
For further details see:
2 Supercharged Growth Stocks Billionaires Can't Stop Buying